Company Filing History:
1 out of 2 
1 out of 1 
1 out of 8 Years Active: 2024-2025
Title: The Innovations of Ran Pang
Introduction
Ran Pang is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biomedicine, particularly in the development of therapeutic antibodies. With a total of 2 patents, his work focuses on addressing immune-related disorders and tumors.
Latest Patents
One of his latest patents is titled "Anti-TNFR2 antibody and use thereof." This patent provides an antibody or an antigen-binding fragment capable of specifically binding to TNFR2. The antibody is designed to regulate the function of immune cells and may serve as a medicament for treating diseases related to immune disorders, such as tumors. Additionally, he has developed a patent for "Drug combination and use for treating tumors," which relates to the combination of IN10018 and an epidermal growth factor receptor tyrosine kinase inhibitor for tumor treatment.
Career Highlights
Ran Pang has worked with prominent companies in the pharmaceutical industry, including Jiangsu Simcere Pharmaceutical Co., Ltd and Simcere Bio-pharmaceutical Technology, Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Ran has collaborated with notable colleagues, including Xinyan Zhao and Xiaofeng Zhao. Their combined efforts have further advanced research in the field of biomedicine.
Conclusion
Ran Pang's innovative work in developing therapeutic antibodies and drug combinations highlights his significant contributions to medical science. His patents reflect a commitment to addressing critical health challenges, particularly in the treatment of tumors and immune-related disorders.